Literature DB >> 14568574

Sex steroid hormone metabolism takes place in human ocular cells.

Miguel Coca-Prados1, Sikha Ghosh, Yugang Wang, Julio Escribano, Annakaisa Herrala, Pirkko Vihko.   

Abstract

Steroids are potentially important mediators in the pathophysiology of ocular diseases. In this study, we report on the gene expression in the human eye of a group of enzymes, the 17beta-hydroxysteroid dehydrogenases (17HSDs), involved in the biosynthesis and inactivation of sex steroid hormones. In the eye, the ciliary epithelium, a neuroendocrine secretory epithelium, co-expresses the highest levels of 17HSD2 and 5 mRNAs, and in lesser level 17HSD7 mRNA. The regulation of gene expression of these enzymes was investigated in vitro in cell lines, ODM-C4 and chronic open glaucoma (GCE), used as cell models of the human ciliary epithelium. The estrogen, 17beta-estradiol (10(-7) M) and androgen agonist, R1881 (10(-8) M) elicited in ODM-C4 and GCE cells over a 24 h time course a robust up-regulation of 17HSD7 mRNA expression. 17HSD2 was up-regulated by estradiol in ODM-C4 cells, but not in GCE cells. Under steady-state conditions, ODM-C4 cells exhibited a predominant 17HSD2 oxidative enzymatic activity. In contrast, 17HSD2 activity was low or absent in GCE cells. Our collective data suggest that cultured human ciliary epithelial cells are able to metabolize estrogen, androgen and progesterone, and that 17HSD2 and 7 in these cells are sex steroid hormone-responsive genes and 17HSD7 is responsible to keep on intra/paracrine estrogenic milieu.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568574     DOI: 10.1016/j.jsbmb.2003.08.001

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  Progesterone treatment in two rat models of ocular ischemia.

Authors:  Rachael S Allen; Timothy W Olsen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Yuliya Oumarbaeva; Irina Lucaciu; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

2.  Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion: Progesterone receptor levels may play an important role.

Authors:  Rachael S Allen; Iqbal Sayeed; Yuliya Oumarbaeva; Katherine C Morrison; Paul H Choi; Machelle T Pardue; Donald G Stein
Journal:  Restor Neurol Neurosci       Date:  2016-11-22       Impact factor: 2.406

Review 3.  Is Estrogen a Therapeutic Target for Glaucoma?

Authors:  Samantha S Dewundara; Janey L Wiggs; David A Sullivan; Louis R Pasquale
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

Review 4.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

5.  Molecular basis for involvement of CYP1B1 in MYOC upregulation and its potential implication in glaucoma pathogenesis.

Authors:  Suddhasil Mookherjee; Moulinath Acharya; Deblina Banerjee; Ashima Bhattacharjee; Kunal Ray
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

Review 6.  Estrogens and neuroprotection in retinal diseases.

Authors:  D Maneesh Kumar; James W Simpkins; Neeraj Agarwal
Journal:  Mol Vis       Date:  2008-08-11       Impact factor: 2.367

7.  Testosterone Pathway Genetic Polymorphisms in Relation to Primary Open-Angle Glaucoma: An Analysis in Two Large Datasets.

Authors:  Jessica N Cooke Bailey; Puya Gharahkhani; Jae H Kang; Mariusz Butkiewicz; David A Sullivan; Robert N Weinreb; Hugues Aschard; R Rand Allingham; Allison Ashley-Koch; Richard K Lee; Sayoko E Moroi; Murray H Brilliant; Gadi Wollstein; Joel S Schuman; John H Fingert; Donald L Budenz; Tony Realini; Terry Gaasterland; William K Scott; Kuldev Singh; Arthur J Sit; Robert P Igo; Yeunjoo E Song; Lisa Hark; Robert Ritch; Douglas J Rhee; Douglas Vollrath; Donald J Zack; Felipe Medeiros; Thasarat S Vajaranant; Daniel I Chasman; William G Christen; Margaret A Pericak-Vance; Yutao Liu; Peter Kraft; Julia E Richards; Bernard A Rosner; Michael A Hauser; Jamie E Craig; Kathryn P Burdon; Alex W Hewitt; David A Mackey; Jonathan L Haines; Stuart MacGregor; Janey L Wiggs; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.